Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03847519
Title Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Advaxis, Inc.
Indications

lung non-small cell carcinoma

Therapies

ADXS-503 + Pembrolizumab

ADXS-503

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST